Prognostic Value of Promoter Hypermethylation of Retinoic Acid Receptor Beta (RARB) and CDKN2 (p16/MTS1) in Prostate Cancer

Objective: The molecular mechanism of prostate cancer is poorly understood. The aim of the study was to investigate the prevalence and prognostic value of promoter hypermethylation of retinoic acid receptor beta (RARB) and p16 among benign prostatic hyperplasia (BPH) and prostate cancer patients. Me...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Chinese journal of cancer research 2011-12, Vol.23 (4), p.306-311
Hauptverfasser:	Ameri, A., Alidoosti, A., Hosseini, Y., Parvin, M., Emranpour, M. H., Taslimi, F., Salehi, E., Fadavi, P.
Format:	Artikel
Sprache:	eng
Schlagworte:	Medicine Medicine & Public Health Original Original Article
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!